Clinical characteristics and statin eligibility of patients under 50 with ST‐elevation myocardial infarction
Key Points:
- Young STEMI patients often have traditional (e.g., smoking, dyslipidemia) and non-traditional (e.g., substance use, genetic predisposition) risk factors.
- A significant proportion may not meet guideline-based statin eligibility before their event, suggesting limitations in current risk assessment models.
- Findings emphasize the need for early lipid screening and personalized preventive strategies in younger at-risk individuals.
Description
This study examines the clinical profiles of young patients (<50 years) presenting with STEMI and evaluates their eligibility for statin therapy based on current guidelines. It highlights risk factors, lipid profiles, and potential gaps in preventive cardiovascular care.
Be the first to review “Clinical characteristics and statin eligibility of patients under 50 with ST‐elevation myocardial infarction”
Reviews
There are no reviews yet.